Why is Ipca Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
The company has declared Positive results for the last 10 consecutive quarters
- OPERATING CF(Y) Highest at Rs 1,378.12 Cr
- PAT(Latest six months) At Rs 794.38 cr has Grown at 42.37%
- ROCE(HY) Highest at 22.10%
3
Stock is technically in a Mildly Bullish range
- Multiple factors for the stock are Bullish like MACD, KST and OBV
4
With ROE of 16.6, it has a Fair valuation with a 5.4 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 28.40%, its profits have risen by 47.1% ; the PEG ratio of the company is 0.7
5
High Institutional Holdings at 48.12%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks
7
Market Beating Performance
- The stock has generated a return of 28.40% in the last 1 year, much higher than market (BSE500) returns of 0.37%
How much should you hold?
- Overall Portfolio exposure to Ipca Labs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Ipca Labs for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
Ipca Labs
28.4%
1.01
28.18%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
13.21%
EBIT Growth (5y)
10.62%
EBIT to Interest (avg)
21.14
Debt to EBITDA (avg)
0.89
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.99
Tax Ratio
24.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.12%
ROCE (avg)
17.19%
ROE (avg)
11.59%
Valuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
40
Price to Book Value
5.38
EV to EBIT
24.12
EV to EBITDA
19.63
EV to Capital Employed
5.57
EV to Sales
4.42
PEG Ratio
0.69
Dividend Yield
0.33%
ROCE (Latest)
23.08%
ROE (Latest)
16.60%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Movement
16What is working for the Company
OPERATING CF(Y)
Highest at Rs 1,378.12 Cr
PAT(Latest six months)
At Rs 794.38 cr has Grown at 42.37%
ROCE(HY)
Highest at 22.10%
DPS(Y)
Highest at Rs 6.00
NET SALES(Q)
Highest at Rs 2,909.94 cr
PBDIT(Q)
Highest at Rs 673.48 cr.
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.38 times
Loading Valuation Snapshot...
Here's what is working for Ipca Labs
Profit After Tax (PAT) - Latest six months
At Rs 794.38 cr has Grown at 42.37%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 1,378.12 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 2,909.94 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 673.48 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Dividend per Share (DPS) - Annually
Highest at Rs 6.00
in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (Rs)
Here's what is not working for Ipca Labs
Debtors Turnover Ratio- Half Yearly
Lowest at 4.38 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio